[1]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,(04):138-139.[doi:10.3969/j.issn.1006-1959.2019.04.044]
 ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Medical Information,2019,(04):138-139.[doi:10.3969/j.issn.1006-1959.2019.04.044]
点击复制

乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年04期
页码:
138-139
栏目:
药物与临床
出版日期:
2019-02-15

文章信息/Info

Title:
Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn
文章编号:
1006-1959(2019)04-0138-02
作者:
张恺悦陈幼琼
(贵州省人民医院烧伤整形外科,贵州 贵阳 550002)
Author(s):
ZHANG Kai-yueCHEN You-qiong
(Department of Burn and Plastic Surgery,Guizhou Provincial People's Hospital,Guiyang 550002,Guizhou,China)
关键词:
乌司他丁血必净脓毒症凝血功能
Keywords:
UlinastatinXuebijingSepsisCoagulation
分类号:
R459.7
DOI:
10.3969/j.issn.1006-1959.2019.04.044
文献标志码:
A
摘要:
目的 研究乌司他丁、血必净联合治疗对烧伤后脓毒症凝血功能及全身炎性反应影响。方法 回顾分析2016年6月~2018年6月在我院诊治的146例烧伤后脓毒症患者临床资料,随机分为对照组和观察组,各73例。对照组采用常规综合治疗,观察组在对照组基础上采用乌司他丁联合血必净治疗,观察两组治疗患者治疗前后凝血功能及全身炎性反应情况。结果 治疗后,观察组凝血酶原时间(PT)、纤维蛋白原(FIB)、血纤维蛋白原降解产物(FDP)、部分凝血活酶时间(APTT)、凝血酶时间(TT)均优于对照组,差异均有统计学意义(P<0.05);观察组TNF-α、IL-6、IL-10、CRP水平改善优于对照组,差异有统计学意义(P<0.05)。结论 乌司他丁、血必净联合治疗对烧伤后脓毒症可以改善凝血功能,减轻炎性反应,促进患者的康复。
Abstract:
Objective To study the effects of combination therapy with ulinastatin and Xuebijing on coagulation function and systemic inflammatory response in post-burn sepsis. Methods The clinical data of 146 patients with post-burn sepsis diagnosed in our hospital from June 2016 to June 2018 were retrospectively analyzed and randomly divided into control group and observation group, 73 cases each. The control group was treated with conventional comprehensive treatment. The observation group was treated with ulinastatin combined with Xuebijing on the basis of the control group. The coagulation function and systemic inflammatory response of the two groups were observed before and after treatment. Results After treatment, prothrombin time (PT), fibrinogen (FIB), fibrinogen degradation product (FDP), partial thromboplastin time (APTT), and thrombin time (TT) were observed in the observation group superior to the control group, the difference was statistically significant (P<0.05); observation group TNF-α, The levels of IL-6, IL-10 and CRP were better than those of the control group,the difference was statistically significant (P<0.05). Conclusion Combined treatment with ulinastatin and Xuebijing can improve blood coagulation, reduce inflammatory reaction and promote rehabilitation of patients with post-burn sepsis.

参考文献/References:


[1]高戈,冯喆,常志刚,等.2012国际脓毒症及脓毒性休克诊疗指南[J].中华危重病急救医学,2013,25(8):501-505.
[2]王帅.乌司他丁对重症脓毒症患者凝血功能影响的临床研究[J].中国实用医药,2013,8(21):185-186.
[3]陈炜,赵磊,牛素平,等.不同炎症因子对细菌性血流感染所致脓毒症患者的早期诊断价值[J].中华危重病急救医学,2014,26(3):165-170.
[4]张赤,罗华,张声,等.血必净、乌司他丁联合治疗脓毒症时对凝血机制的影响[J].内科急危重症杂志,2015,16(3):145-147.
[5]茅尧生,吕铁,孟东亮,等.血必净联合乌司他丁对重症脓毒症的疗效及作用机制的研究[J].中国急救医学,2014,12(28):1077-1080.

相似文献/References:

[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
 ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,(04):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]刘 云,于洪波.乌司他丁与生长抑素治疗重症急性胰腺炎临床疗效观察[J].医学信息,2019,(01):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
 LIU Yun,YU Hong-bo.Clinical Efficacy of Ulinastatin and Somatostatin in the Treatment of Severe Acute Pancreatitis[J].Medical Information,2019,(04):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
[3]甘维桃,曾 凡,冮绍斌.乌司他丁对膝关节置换术后关节炎症及周围肿胀的影响[J].医学信息,2019,(02):161.[doi:10.3969/j.issn.1006-1959.2019.02.049]
 GAN Wei-tao,ZENG Fan,GANG Shao-bin.Effect of Ulinastatin on Joint Inflammation and Peripheral Swelling after Knee Joint Replacement[J].Medical Information,2019,(04):161.[doi:10.3969/j.issn.1006-1959.2019.02.049]

更新日期/Last Update: 2019-03-07